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a b s t r a c t
We investigated cold plasma effects on acute wounds of mice. The mice were classiﬁed into experimental
and control groups. In the former, wounds were treated using cold plasma once daily for 1 min, and then
covered with hydrocolloid dressing; wounds in the control were left to heal under hydrocolloid dressing.
Daily evaluation was conducted for 15 days. General and speciﬁc staining was applied to evaluate
re-epithelialization, neutrophil, macrophage, myoﬁbroblast and transforming growth factor beta. It was
found that cold plasma accelerated wound healing by 1 day. Plasma may promote the late phase of
inﬂammation, accelerate re-epithelialization and increase wound contraction.
& 2014 Elsevier GmbH. All rights reserved.
1. Introduction
Cutaneous wound healing is a complex physiological process
consisting of orchestrated events communicated by collaborative
factors [1]. The utilization of various exogenous agents from
natural products like Indonesian honey [2] and oleic or linoleic
acid [3] to physical tools like light [4] and laser [5] has been shown
to enhance the overlapping healing phases, including inﬂamma-
tion, proliferation and remodeling [1]. Among these, wound
therapy based on cold plasma, that is, non-equilibrium plasma
(with an electron temperature much higher than the gas tem-
perature), with a low temperature of ionized gas [6], has opened
the possibility of a paradigm shift in biomedical therapy [7]; it has
drawn substantial attention from both plasma and wound care
scientists since its feasibility to work through living tissue [8,9]
and its potency for resolving problems in contemporary wound
care were demonstrated [10]. As the fourth state of matter [6],
plasma has the ability to produce controllable reactive species, like
nitric oxide (NO) and hydroxyl radicals (OH), upon contacting the
open air [11], as well as OH radicals and hydrogen peroxide (H2O2)
upon contacting an aqueous solution [12]. Although the clinical
efﬁcacy of carefully controlled treatment with cold plasma for
killing bacteria colonizing chronic wounds [13,14] and improving
wound healing [15] has been demonstrated, there have been few
studies about the effects of cold plasma and its mechanism of
action on acute wounds in mouse models.
Re-epithelialization and wound contraction are two key events
in the healing of full-thickness wounds. The former is central to
wound closure, which is closely connected to granulation tissue
formation in a spatiotemporal manner [16], and the latter may
account for up to a 40% decrease in wound size, correlated with
the expression of myoﬁbroblasts [17]. It is well established that
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these processes are inﬂuenced by the presence of growth factors
like epidermal growth factor (EGF), keratinocyte growth factor
(KGF) and transforming growth factor (TGF) [15], which are likely
mediated by reactive oxygen species (ROS) and NO [18–20].
Although the mechanism of the interaction between cold
plasma and cells or living tissue is still unclear [21], several studies
have reported the effects of cold plasma on key wound-related
cells or sub-cells, included promoting the proliferation of ﬁbro-
blasts [22] and endothelial cells [23], as well as the growth of
epithelial cells [24], inhibiting the migration of ﬁbroblasts [25] and
their surface expression [26], and activating integrin of ﬁbroblasts
and epithelial cells [27]. Interestingly, some of these effects are
likely to be similar to the activities of natural ROS and/or NO
during wound healing, particularly cold plasma's effects on the
proliferation of both ﬁbroblasts and endothelial cells [19]. There-
fore, the aim of this study was to assess the effects of cold plasma
on acute cutaneous wound healing in an in vivo scenario with a
focus on re-epithelialization and wound contraction.
2. Materials and methods
2.1. Cold plasma jet characterization and mouse wound positioning
The cold atmospheric pressure plasma jet system that we used
here is similar to the device developed by Teschke et al. [28]. Two
metal ring electrodes were used around the quartz tube for the
cold atmospheric pressure plasma jet system provided by the
Division of Electrical Engineering and Computer Science, Kana-
zawa University, Kanazawa, Japan. It had a quartz tube with a
1.6 mm inner diameter. A low-frequency (20 kHz) AC high
voltage, with a peak-to-peak voltage of 25 kV, was applied to the
two ring electrodes when commercial argon gas (99.995% purity)
at a ﬂow rate of 5 slm was injected from one end of the quartz
tube. The discharge voltage and discharge current were measured
with a high-voltage probe (P6015A; Tektronix, Inc., Tokyo, Japan)
and a current probe (8585C; Pearson Electronics, Palo Alto, CA,
USA). The average power density at the electrode was 85 W/cm2 in
this study.
During its treatment, a mouse wound was positioned about
15 mm under the nozzle of the plasma reactor, and was not
touched by its jet. Optical emission spectroscopy (OES) measure-
ment at about 10 mm under the nozzle showed the emissions of
the OH (A-X transition) transition near 309 nm, N2 (C-B transition)
(band head maximum at 337 nm) [29] and Ar I (maximum
763 nm). This observation revealed the presence of both hydroxyl
radical (OH) and nitrogen-based reactive species in the gas phase
during its generation (Fig. 1).
In order to evaluate its thermal effect on living tissue, a cold
plasma jet was tested on normal skin of anesthetized mouse prior
to its application on wound. On the basis of measurement with a
non-contact infra-red digital camera (F30S; NEC Avio Infrared
Technologies, Tokyo, Japan) at room temperature (24 1C), during
cold plasma treatment, the temperature of the inﬂuenced skin, of
non-inﬂuenced skin and of the end of the plasma nozzle were
32.3 1C, 28.8 1C and 36.6 1C, respectively. After the session, injury
was not observed on treated skin.
2.2. Animals and experimental protocol
Forty BALB/c CrSlc male mice aged 8 weeks (Sankyo Lab Service
Corporation, Inc., Toyama, Japan) and weighing 21.3–26.0 g were
used. They were caged individually in an air-conditioned room at
25.072.0 1C with light from 08:45 to 20:45 h. Water and labora-
tory chow were given freely. The experimental protocol and
animal care were in accordance with the Guidelines for the Care
and Use of Laboratory Animals of Kanazawa University, Japan
(AP: 112243).
2.3. Wound healing model and plasma treatment
After being completely anesthetized by the injection of pento-
barbital sodium (0.5 mg/10 g weight) into the peritoneal cavity, we
held the skin of the dorsum including the subcutaneous tissue
between thumb and ﬁnger, folded it along the apex of the median
line on the dorsum in a U-shape, put both sides of the skin
together, made two holes through the skin with a sterile dispo-
sable 2 mm biopsy punch (Kai Industries Co. Ltd., Gifu, Japan) and
ﬁnally made two circular (2 mm in diameter) full-thickness skin
wounds including the panniculus carnosus muscle and a part of
the subcutaneous tissue on both sides of the dorsum of the mouse.
Subsequently, the mice were randomly classiﬁed into two groups:
(1) experimental group, with wounds treated once daily by a cold
plasma jet during 1 min in one spot on the wound, and then
covered by hydrocolloid dressing (Tegaderm; 3 M Health Care,
Tokyo, Japan) to maintain its moist environment; and (2) control
group, with wounds only allowed to heal under hydrocolloid
dressing.
2.4. Macroscopic evaluation
The day whenwounds were made was designated as day 0, and
the process of wound healing was observed daily from days 0 to 15
after wounding. Before observation, the surrounding environment
of wounds was cleaned with saline solution. Wounded edges were
traced on polypropylene sheets and photographs were taken every
day. The traces on the sheets were captured with a scanner onto a
personal computer using Adobe Photoshop Elements 7.0 (Adobe
System Inc., Tokyo, Japan), and the areas of wounds were calcu-
lated using image analysis software Scion Image Beta 4.02 (Scion
Corporation, Frederick, Maryland, USA).
2.5. Calculation of healing day
The day of wound healing was calculated based on a graph of
the ratios of areas to original areas. Initially, the overall trend of
such a graph was evaluated. Wound healing day was plotted on
the y-axis when the trend of reduction of wound size started to






























Fig. 1. Optical emission spectroscopy (OES) measurement of cold plasma jet near
the wound surface (about 10 mm under the nozzle of the cold plasma reactor)
during treatment. OH and nitrogen-based reactive species were identiﬁed.
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2.6. Histology
The mice were euthanized by a massive pentobarbital sodium
IP injection on days 3, 7, 11 or 15 post-wounding. The wounds and
the surrounding normal skin were excised for an area of about
1010 mm2, stapled onto polypropylene sheets to prevent over-
contraction of the samples and ﬁxed in neutral buffered 10%
formalin solution in 0.01 M phosphate buffer, pH 7.4, for about
15 h. The samples were then rinsed in 0.01 M phosphate-buffered
saline (PBS) for about 8 h. Subsequently, they were dehydrated in
an alcohol series, cleaned in xylene and embedded in parafﬁn to
prepare serial 5-mm sections. Next, the sections were separated
into two groups: for general staining using hematoxylin-eosin
(H&E) for re-epithelialization observation, and for speciﬁc staining
using immunohistochemical staining.
2.7. Immunohistochemistry (IHC)
Immunohistochemical staining for myoﬁbroblasts was con-
ducted for the sections from all days of mouse harvesting (days 3,
7, 11 and 15), while that for macrophages, neutrophils and trans-
forming growth factor beta (TGF-β) was only conducted for the
sections from days 3 and 7 of mouse harvesting because of a
limitation in the number of sections. In brief, the immunohisto-
chemical staining was performed as follows. After deparafﬁnization
and rehydration, antigen unmasking was accomplished by heating
slides in a water bath followed by incubation in sodium citrate
buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0) for 20 min
at approximately 100 1C. Then, the slides were washed with PBS, pH
7.4, covered with 0.03% hydrogen peroxide to block endogenous
peroxidase for 5 min at room temperature, rinsed with distilled
water, covered with protein-free normal serum for 10 min at room
temperature and then rinsed with PBS. Subsequently, sections were
incubated with primary and secondary antibodies as follows:
a. For neutrophil identiﬁcation: Sections were incubated with anti-
neutrophil antibody (Abcam Japan, Tokyo, Japan) at a dilution of
1:100 in PBS at 4 1C overnight, and then with secondary antibody
polyclonal rabbit anti-rat immunoglobulins/HRP (Dako, North
America Inc., CA)þmouse serum (Dako North America Inc., CA)
(1:100 in PBS) at room temperature for 30 min.
b. For macrophage identiﬁcation: Sections were incubated with anti-
macrophage-3 antibody (Abcam Japan, Tokyo, Japan) at a dilution
of 1:100 in PBS at 4 1C overnight and then with secondary
antibody polyclonal rabbit anti-rat immunoglobulins/HRP (Dako,
North America Inc., CA)þmouse serum (Dako North America Inc.,
CA) (1:100 in PBS) at room temperature for 30 min.
c. For myoﬁbroblast identiﬁcation: Sections were incubated with
anti-α-smooth muscle actin (anti-α-SMA) (Abcam Japan, Tokyo,
Japan) (1:100 in Tween-PBS) at 4 1C overnight, and then
with secondary antibody Dako EnVisionþSystem-HRP labeled
polymer anti-mouse (Dako North America Inc., CA) at room
temperature for 30 min.
d. For TGF-β identiﬁcation: Sections were incubated with anti-TGF-
β (1:100 in PBS) at 4 1C overnight, and then with secondary
antibody Dako EnVisionþSystem-HRP labeled polymer anti-
mouse (Dako North America Inc., CA) at room temperature for
30 min.
After completion of the incubation with the secondary antibody,
the sections were reacted with 3,30-diaminobenzidine substrate
(Dako ENVISION Kit/HRP (DAB), Dako Japan, Kyoto, Japan) for staining
for about 2–5min at room temperature. Finally, counterstaining was
conducted using hematoxylin. As negative controls, samples were
prepared using the same procedure with PBS instead of the ﬁrst
antibody.
2.8. Microscopic observations
On the basis of the results of hematoxylin-eosin staining,
the percentage of re-epithelialization was calculated as follows:
100% (length of new epithelium/length of wound between
wound edges). In addition, on the basis of the results of immuno-
histochemical staining, the numbers of neutrophils, macrophages,
myoﬁbroblasts and cells stained with TGF-β through observation
using an Olympus BX50 light microscope (Olympus, Tokyo, Japan)
at magniﬁcation 400 were also counted. Images were captured
with an Olympus DP72 digital camera and Olympus DP2-BSW
software. Three squares were selected at each wound margin and
the center of the wound, on four serial sections per wound. The
data are presented as the mean number of stained cells counted
in the 12 squares; four serial wound sections per wound were
analyzed.
2.9. Statistical analysis
Data were subjected to statistical analyses using SPSS 16.0.
Differences between the experimental and control groups for the
ratio of wound area average to original wound area and the
calculation of healing day were evaluated by two-tailed unpaired
t-tests and P-values o0.05 were considered signiﬁcant. Differ-
ences between the experimental and control groups for the results
of histological staining were evaluated by ANOVA followed by the
Tukey test and P-values o0.05 were considered signiﬁcant.
3. Results
3.1. Macroscopic evaluation
Immediately after cold plasma irradiation, the wound surfaces
in the experimental group seemed drier than those in the control
group. Wounds were observed daily (Fig. 2). There were no
particular differences regarding the appearance of the wound
surfaces between the experimental and control groups during this
observation. Apparent differences just in the wound size were
found for several days of this observation period.
Wounds in both the experimental and the control groups
experienced slight expansion (edema) on day 1 and then
decreased gradually until the end of the observation period. On
days 1–3, there was exudate on the surface of the wounds in the
two groups. The wound area of the experimental group was
smaller than that of the control from days 4 to 15. From days
5 to 15, the surfaces of the wounds in all groups were mostly fresh
with no exudate.
3.2. Wound area evaluation and day of wound healing
The ratios of wound areas to original areas from day 0 both
until day 15 and until the day of wound healing were determined
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Fig. 2. Macroscopic observation of wound healing.
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Fig. 3. (a) Ratio of areas to original areas during wound healing. On days 3, 4, 5, 6 and 8, the treated wound was signiﬁcantly smaller than that of the control. (b) Day of
wound healing. Experimental wounds healed signiﬁcantly faster, by one day, than those of the control.
Control (3d)Experiment (3d)
Control (3d)Experiment (3d)
Fig. 4. (a) Percentage of re-epithelialization during wound healing. (b) New epithelial image on day 3 of wound healing: (1 and 3) HE staining of the experimental group.
(2 and 4) HE staining of the control. AB, CD, EF and GH show the lengths of new epithelium. IJ and KL also reveal the lengths of new epithelium at magniﬁcation 200 .
Re-epithelialization increased more rapidly in the experimental group than in the control.
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area for the experimental group were signiﬁcantly lower than
those for the control group (Po0.05). On the other hand, on days
9–15, the ratios of areas to the original area for the experimental
group were mostly the same as those for the control group
(P40.05). Days of wound healing for the experimental and control
groups were 8.070.6 and 9.071.3, respectively (Fig. 3b). These
two means were signiﬁcantly different (P¼0.04).
3.3. Cold plasma accelerated re-epithelialization
Re-epithelialization during wound healing was observed (Fig. 4).
On day 3, the percentages of re-epithelialization were signiﬁcantly
different between the experimental group and the control group
(Po0.001), with the former being more than 25% greater than the
latter. The percentages of re-epithelialization of both increased
dramatically from days 3 to 7 (control group: Po0.001; experimen-
tal group: Po0.001). On day 7, the percentages of re-epithelialization
of the two groups were similar (P¼0.999). On days 11 and 15, all
wounds in all groups were covered by new epithelium.
3.4. Myoﬁbroblast count
Myoﬁbroblast number on day 3 was evaluated. On this day, a
few myoﬁbroblasts were observed in the experimental group. On
the other hand, no myoﬁbroblasts were observed in the control.
Myoﬁbroblasts were counted on days 7, 11 and 15 (Fig. 5). The
number of myoﬁbroblasts per mm2 in the experimental group
peaked on day 7 and then decreased gradually until day 15,
while that in the control was stable on days 7 and 11 and then
decreased on day 15. On day 7, the number of myoﬁbroblasts in
the experimental group was higher than that in the control group,
but the two means were not signiﬁcantly different (P¼0.557).
On the other hand, on days 11 and 15, the numbers of myoﬁbro-
blasts in the experimental group were slightly lower than those in
the control, but the two means were not signiﬁcantly different
(11 days: P¼0.990, 15 days: P¼0.994). On day 15, the numbers of
myoﬁbroblasts in the experimental group and the control were
lower than those on day 7. The two means in the former group
were signiﬁcantly different (Po0.001), but those in the latter were
not (P¼0.148).
3.5. Neutrophil count
Numerous neutrophils were observed in the experimental group
and the control group on days 3 and 7 after wounding (Fig. 6).
On day 3, the numbers of neutrophils per mm2 in the experimental
and control groups were relatively similar and were not signiﬁ-
cantly different (P¼0.966). On day 7, the number of neutrophils in
the experimental group was lower than that in the control group,
but the two means were not signiﬁcantly different (P¼0.762). The
Control ( 7 days) Experiment ( 7 days )
20µm 20µm
20µm20µm
Experiment (15 days) Control (15 days)
Fig. 5. (a) Histogram of myoﬁbroblast number on days 7, 11 and 15. By day 7, myoﬁbroblast number in the experimental group was greater than that in the control, but by







Fig. 6. (a) Histogram for neutrophil number on days 3 and 7. Neutrophil number of the experimental group was signiﬁcantly lower than that of the control at day 7.
(b) Immunohistochemical staining for neutrophils. Black arrows show neutrophils colored brown.
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number of neutrophils in the two groups decreased rapidly from
days 3 to 7 (experimental group: Po0.05; control group: Po0.05).
3.6. Macrophage count
Numerous macrophages in the experimental group and the
control group were observed on days 3 and 7 after wounding
(Fig. 7). On these different observation days, the macrophage
number per mm2 in the experimental group was lower than that
in the control, but the two means were not signiﬁcantly different
(day 3: P¼0.203; day 7: P¼0.676). Macrophage numbers in the
control group decreased signiﬁcantly from days 3 to 7 (Po0.05).
Macrophage number in the experimental group also decreased
from days 3 to 7, but the two means were not signiﬁcantly
different (P¼0.913).
3.7. Count of cells stained with TGF-beta
Numerous cells stained with transforming growth factor beta
(TGF-β) were observed in the experimental group and the control
group on days 3 and 7 after wounding (Fig. 8). On day 3, the
number of cells with TGF-β per mm2 in the experimental group
was lower than that in the control group, but the two means were
not signiﬁcantly different (P¼0.688). In contrast, on day 7, the
number of cells with TGF-β in the experimental group was slightly
higher than that in the control group, but the two means were not
signiﬁcantly different (P¼0.897). The numbers of cells with TGF-β
in the experimental group were similar on days 3 and 7 (P¼0.991).
On the other hand, the number of cells with TGF-β in the control
group decreased from days 3 to 7, but the two means were not
signiﬁcantly different (P¼0.209).
4. Discussion
This research design separated between treated and untreated
mice because it was considered that cold plasma produced not only
reactive species like nitric oxide (NO) and hydrogen peroxide (H2O2)
that in appropriate dosage may have efﬁcacy for wound healing [20],
but also that temperature change may have the same effect [30].
While the former may work in a locally speciﬁc manner [25], the
latter may operate at a physiologically systematic level under a
hypothalamic regime [31]. In this design, there were twowounds in a
mouse, on the left side and the right side. When the left wound was
subjected to plasma treatment, the right wound may also have been
inﬂuenced by its warmth. Therefore, it was important to ensure that
there was no inﬂuence of plasma agents in the untreated mice.
Although this approach was intended to mimic the clinical setting in
a hospital, it differed from the work of Heinlin et al. [15], who placed
two in the same patient.
On the basis of histological data from 3 days after wounding,
we showed that cold plasma is efﬁcacious for the acceleration of
wound re-epithelialization. This ﬁnding seemed to be in line with
Nastuta et al. and Heinlin et al. Nastuta et al. reported that helium
cold plasma treatment accelerated the re-epithelialization of burn
wound tissue [32]. Furthermore, by an investigation of clinical
standardized photographs of wounds on a skin graft donor site,
Heinlin et al. reported that argon cold plasma treatment had a
positive effect [15]. However, there were no histological data in
these two reports. This is the ﬁrst report describing such ﬁndings
on this topic supported by the histological data.
In the present study, we found that cold plasma treatment
caused acceleration of wound healing by one day compared with
that of untreated wounds. Such reduction in the period required
for wound healing may be correlated with the early presence and
the peak of myoﬁbroblasts in the cold plasma-treated wounds by
days 3 and 7 after wound creation, as we observed. It is well
established that there are multiple ways by which myoﬁbroblasts
originate, one of which is through the differentiation from





Control (3 days)20µm 20µm
20µm20µm
Fig. 7. (a) Histogram for macrophage number on days3 and 7. Macrophage number of the experimental group was signiﬁcantly lower than that of the control on days 3 and
7. (b) Immunohistochemical staining for macrophages. Black arrows show macrophages colored brown.
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ﬁbroblasts to myoﬁbroblasts mediated by activated transforming
growth factor beta (TGF-β) [33]. Cold plasma may play two main
roles in inﬂuencing this mechanism: (1) promoting the prolifera-
tion of ﬁbroblasts on the wound surface, in line with another
reported study [21] in which the higher the number of ﬁbroblasts,
the possibly higher the number of myoﬁbroblasts; and (2) activat-
ing “latent TGF-β”on the wound surface to become “active TGF-β”,
which may increase myoﬁbroblasts. The possibility of cold plasma
activating TGF-β may involve one or both of two possible mechan-
isms as follows. The ﬁrst of these is ROS-based activation, as
described previously [34,35]. ROS in this context are generated by
cold plasma. Secondly, it could involve integrin-based activation
by cold plasma, as also reported elsewhere [26].
The activation of TGF-β may be detected by an increase of the
cells stained with anti-TGF-β antibody, but in this research, we
found no signiﬁcant difference in the number of cells with TGF-β
between treated and untreated wounds on days 3 and 7 after
wounding. This may be in line with a report mentioned previously
that stated that the conventional histological method, as used
in this research, could not clearly differentiate between latent
TGF-β and active TGF-β [36]. Thus, it is difﬁcult to determine
whether immunohistochemical staining of TGF-β, as in this
research, was associated with latent TGF-β, active TGF-β, or both.
In the healing of normal wounds, inﬂammation is classiﬁed
into early and late phases. Neutrophil-rich and mononuclear-cell-
rich inﬁltrates are representative of the former and the latter,
respectively [1]. In this research, the observation that by 3 days
after wound creation, there was the same number of neutrophils
in the experimental and control groups suggested that there was
no difference in the time course of the early phase of inﬂammation
between them. It showed that cold plasma had no effect on the
early phase of inﬂammation. At a later stage, the observation in
this research that by 7 days after injury, there were fewer
macrophages and neutrophils in the experimental group than in
the control suggested that there was an acceleration of the
inﬂammatory phase of repair in the experimental group, so that
the late phase of inﬂammation ended rapidly. So far, it has been
revealed that cold plasma treatment accelerated such a process.
It has also been indicated that treated wounds started the
proliferation phase earlier than untreated ones. This phenomenon
may be correlated with the proliferative effect of cold plasma, as
reported previously [22], and the early presence of myoﬁbroblasts,
as reported in this research.
It is well known that the outcome of acute inﬂammation is
elimination of the noxious stimulus [37]. In this context, Shekhter
et al. discussed the possible inﬂuence of plasma-based NO on the
phagocytosis of macrophages to improve the regeneration of
wounds [38]. Theoretically, acute inﬂammation has two major
components: vascular changes and cellular events [37]. Regarding
the former, plasma may play the important role of inﬂuencing
vascular growth, vascular dilation, and microcirculation normal-
ization, as discussed previously [38]. Regarding the latter, the
direct effect of cold plasma on the events of inﬂammatory cells like
macrophages has been unclear, but as we wrote previously, it was
reported that cold plasma reduced the migration of ﬁbroblasts [25]
and activated their integrin [27]. Migration and integrin activation
are crucial events for family members of leukocytes during the
inﬂammatory phase. If the effects of cold plasma on ﬁbroblasts
and those on inﬂammatory cells are the same, this could be used
to demonstrate the mechanism of the healing effect of cold plasma
during the late stage of the inﬂammatory phase.
Cold plasma treatment is characteristically topical, with the
maximum penetration depth of its reactive oxygen species (ROS)/
reactive nitrogen species (RNS) being at most a few tens of
micrometers [39]. From a cellular study, it was also reported that
the effects of cold plasma were conﬁned to the area that can be
reached by ROS/RNS [25]. In the present research, it is unclear
whether reactive species of a cold plasma jet could directly reach
cells related to wound contraction, myoﬁbroblasts and ﬁbroblasts.
However, if this could not be achieved, the hypothesis of Heinlin
et al. should be considered. Heinlin et al. hypothesized that the
effect of cold plasma treatment would probably occur not only in
the treatment area, but also in the adjacent wound area through
microenvironmental modiﬁcation [15].
In this research, we did not detect reactive species of cold
plasma at a distance of 15 mm under the nozzle using an OES
spectrophotometer, but we detected slight temperature change on
normal skin of anesthetized mice at such a distance using an
infrared thermal camera. Of course, the detection of such reactive
species could be achieved by other methods, but the slight
temperature change should also be considered if a microenviron-
mental perspective were applied.
In conclusion, it was determined that cold plasma accelerated
wound healing by one day through the modiﬁcation of re-
epithelialization, the late stage of inﬂammation and wound con-
traction. Cold plasma may inﬂuence the wound healing mechan-
ism at the microenvironmental level through not only its reactive
species, but also its warming effect, simultaneously.
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